Skip to main content
Clinical Trials/NCT02408835
NCT02408835UnknownNot Applicable

A Randomised Controlled Trial Comparing PICO™ Single Use Negative Pressure Wound Therapy System (Smith & Nephew Healthcare Limited, UK) to Conventional Wound Care Following Inguinal Lymphadenectomy for Metastatic Cutaneous Malignancy

South Eastern Health and Social Care Trust2 sites in 1 country22 target enrollmentStarted: July 2015Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
22
Locations
2
Primary Endpoint
Time to wound healing

Study Overview

Brief Summary

This study investigates the use of a negative pressure wound therapy device (PICO™, Smith & Nephew Healthcare, UK) on clean, closed surgical wounds, in patients who are undergoing inguinal lymphadenectomy for metastatic carcinoma of cutaneous origin.

Detailed Description

Patients may develop inguinal lymph node metastases from a variety of cutaneous neoplasms. A number of factors conspire to cause a high rate of wound breakdown and other complications in this patient group. Reported rates of wound healing complications vary in the literature, but tend to affect > 40% of patients.

A new negative pressure wound therapy device is recommended for use in clean, closed surgical wounds (PICO™ system, Smith & Nephew Healthcare, UK). Patients will be randomised to receive either PICO™ system for up to seven days, or conventional dressings, and then assessed for wound healing and other outcome measures.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Histologically- or cytologically-proven inguinal lymph node metastases from neoplasm of cutaneous origin

Exclusion Criteria

  • inability to give informed consent for participation

Outcomes

Primary Outcomes

Time to wound healing

Time Frame: From date of surgery until epithelial integrity is restored at the surgical site. Assessed at least weekly until wound is healed, up to 20 weeks after surgery

Determination of wound healing

Secondary Outcomes

  • Wound infection As defined by Comprehensive Complication Index (CCI)(From date of surgery until wound is healed (epithelial integrity restored at surgical site), up to 20 weeks after surgery.)
  • Need for further surgical interventions to achieve wound healing(From date of surgery until wound is healed, up to 20 weeks after surgery.)
  • Scar appearance (POSAS)(From date of surgery up to one year post-operatively.)
  • Patient reported outcomes (qualitative interview)(From date of surgery to six months post-operatively.)
  • Lymphoedema (Limb volume measurements)(From date of surgery up to one year post-operatively.)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Sandra McAllister

Academic Clinical Lecturer

South Eastern Health and Social Care Trust

Study Sites (2)

Loading locations...

Similar Trials

Negative Pressure Wound Therapy in Groin... | Clinical Trial